Betschel, Stephen
114  Ergebnisse:
Personensuche X
?
1

Long-Term Effectiveness and Safety of Lanadelumab in Patien..:

Bernstein, Jonathan ; Betschel, Stephen ; Busse, Paula...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB242 , 2024
 
?
3

Characterizing the HAE Patient Perspective on First-Line Pr..:

Betschel, Stephen ; Radojicic, Cristine ; van Kooten, Sally...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB86 , 2024
 
?
4

A Core Outcome Set for Efficacy of Acute Treatment of Hered..:

Petersen, Remy S. ; Fijen, Lauré M. ; Apfelbacher, Christian...
The Journal of Allergy and Clinical Immunology: In Practice.  12 (2024)  6 - p. 1614-1621 , 2024
 
?
 
?
7

Effectiveness, Safety, and Patient-Reported Outcomes (PROs)..:

Wedner, H. James ; Bernstein, Jonathan ; Betschel, Stephen...
Journal of Allergy and Clinical Immunology.  151 (2023)  2 - p. AB131 , 2023
 
?
11

The international WAO/EAACI guideline for the management of..:

Maurer, Marcus ; Magerl, Markus ; Betschel, Stephen...
World Allergy Organization Journal.  15 (2022)  3 - p. 100627 , 2022
 
?
 
?
14

Impact of lanadelumab on patient-reported outcomes in hered..:

Busse, Paula ; Zaragoza-Urdaz, Rafael ; Betschel, Stephen...
Journal of Allergy and Clinical Immunology.  149 (2022)  2 - p. AB166 , 2022
 
?
15

Second-dose mRNA COVID-19 vaccine safety in patients with i..:

Iaboni, Aled ; Jindal, Nina ; Betschel, Stephen D..
Journal of Allergy and Clinical Immunology: Global.  1 (2022)  3 - p. 172-174 , 2022
 
1-15